Banks seek to counter FRTB internal model add-on

Parallel shifts and trading desk reshuffles mooted as fix for non-modellable risk factors

chess-pawn
State of play: banks are considering moves to repel non-modellable risk factors

Banks are casting around for ways to reduce the impact of an add-on for non-modellable risk factors in the Basel Committee on Banking Supervision’s new trading book capital rules, including by tweaking their internal models and reorganising trading desks.

The revelations came during a panel discussion at the Traded Risk conference in London yesterday (April 14), which focused on the committee’s Fundamental review of the trading book (FRTB).

Released in January, the final FRTB rules include two

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

The new rules of market risk management

Amid 2020’s Covid-19-related market turmoil – with volatility and value-at-risk (VAR) measures soaring – some of the world’s largest investment banks took advantage of the extraordinary conditions to notch up record trading revenues. In a recent Risk.net…

ETF strategies to manage market volatility

Money managers and institutional investors are re-evaluating investment strategies in the face of rapidly shifting market conditions. Consequently, selective genres of exchange-traded funds (ETFs) are seeing robust growth in assets. Hong Kong Exchanges…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here